BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Cuts Position in Axon Enterprise, Inc. (NASDAQ:AXON)

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp decreased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 12.9% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,960 shares of the biotechnology company’s stock after selling 1,770 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in Axon Enterprise were worth $4,779,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. Blue Trust Inc. increased its position in shares of Axon Enterprise by 987.5% during the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after purchasing an additional 79 shares during the last quarter. Quent Capital LLC lifted its position in Axon Enterprise by 1,875.0% in the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after buying an additional 75 shares during the last quarter. Brooklyn Investment Group purchased a new stake in Axon Enterprise in the third quarter worth approximately $41,000. Asset Dedication LLC bought a new position in Axon Enterprise during the second quarter valued at approximately $47,000. Finally, Planning Capital Management Corp raised its stake in shares of Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after acquiring an additional 55 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on AXON shares. Craig Hallum upped their price objective on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. JMP Securities upped their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. Northland Securities increased their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Needham & Company LLC lifted their price target on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Finally, Robert W. Baird boosted their price objective on Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $427.83.

Axon Enterprise Stock Down 1.6 %

Shares of Axon Enterprise stock opened at $636.39 on Tuesday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12-month low of $229.02 and a 12-month high of $652.22. The company has a market cap of $48.52 billion, a P/E ratio of 164.44, a PEG ratio of 14.24 and a beta of 1.01. The company’s fifty day simple moving average is $488.25 and its two-hundred day simple moving average is $380.19.

Insider Activity

In related news, Director Julie A. Cullivan sold 900 shares of Axon Enterprise stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $353.53, for a total transaction of $318,177.00. Following the sale, the director now directly owns 3,653 shares in the company, valued at $1,291,445.09. The trade was a 19.77 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Patrick W. Smith sold 47,314 shares of the stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $400.07, for a total value of $18,928,911.98. Following the completion of the transaction, the chief executive officer now owns 2,983,802 shares of the company’s stock, valued at approximately $1,193,729,666.14. This trade represents a 1.56 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 135,256 shares of company stock valued at $61,043,370. Corporate insiders own 5.70% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.